Teladoc Health, Inc.
$6.1
▼
-0.19%
2026-04-21 09:45:01
www.teladochealth.com
NYQ: TDOC
Explore Teladoc Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.09 B
Current Price
$6.1
52W High / Low
$9.77 / $4.4
Stock P/E
—
Book Value
$7.77
Dividend Yield
—
ROCE
-6.66%
ROE
-13.93%
Face Value
—
EPS
$-34.2
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
4,648
Beta
2.08
Debt / Equity
75.06
Current Ratio
2.77
Quick Ratio
2.67
Forward P/E
-5.46
Price / Sales
0.36
Enterprise Value
$1.17 B
EV / EBITDA
35.35
EV / Revenue
0.46
Rating
Buy
Target Price
$7.09
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Weave Communications, Inc. | $5.47 | — | $430.21 M | — | -24.81% | -37.56% | $11.32 / $4.24 | $1.05 |
| 2. | Schrödinger, Inc. | $12.8 | — | $944.96 M | — | -31.08% | -26.29% | $27.63 / $10.95 | $4.94 |
| 3. | 10x Genomics, Inc. | $24.59 | — | $3.14 B | — | -12.49% | -5.78% | $26.45 / $7.25 | $6.24 |
| 4. | HealthStream, Inc. | $21.34 | 34.36 | $630.28 M | 0.6% | 5.11% | 5.14% | $34.13 / $19.5 | $11.97 |
| 5. | American Well Corporation | $6.61 | — | $101.3 M | — | -42.01% | -33.67% | $9.15 / $3.71 | $14.34 |
| 6. | TruBridge, Inc. | $23.18 | 77.96 | $339.43 M | — | 6.05% | 2.52% | $26.74 / $13.88 | $12.25 |
| 7. | GoodRx Holdings, Inc. | $2.37 | 26.67 | $811.9 M | — | 7.56% | 4.54% | $5.81 / $1.77 | $1.81 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 642.27 M | 626.44 M | 631.9 M | 629.37 M | 640.49 M |
| Operating Profit | -26.97 M | -35.46 M | -46.03 M | -54.94 M | -42.16 M |
| Net Profit | -25.14 M | -49.51 M | -32.66 M | -93.01 M | -48.41 M |
| EPS in Rs | -0.14 | -0.27 | -0.18 | -0.52 | -0.27 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.53 B | 2.57 B | 2.6 B | 2.41 B |
| Operating Profit | -163.4 M | -208.79 M | -210.5 M | -227.37 M |
| Net Profit | -200.32 M | -1 B | -220.37 M | -13.66 B |
| EPS in Rs | -1.11 | -5.55 | -1.22 | -75.7 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.86 B | 3.52 B | 4.39 B | 4.35 B |
| Total Liabilities | 1.47 B | 2.03 B | 2.07 B | 2.04 B |
| Equity | 1.39 B | 1.49 B | 2.33 B | 2.31 B |
| Current Assets | 1.12 B | 1.66 B | 1.49 B | 1.32 B |
| Current Liabilities | 404.74 M | 941.53 M | 420.62 M | 399.77 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 294.36 M | 293.68 M | 350.02 M | 189.29 M |
| Investing CF | -266 M | -124.05 M | -156.35 M | -167.74 M |
| Financing CF | -551.65 M | 8.31 M | 10.85 M | 6.5 M |
| Free CF | 137.33 M | 169.63 M | 193.67 M | 16.53 M |
| Capex | -157.02 M | -124.05 M | -156.35 M | -172.76 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -1.26% | 8.13% | — | — |
| Earnings Growth % | -354.35% | 98.39% | — | — |
| Profit Margin % | -38.97% | -8.47% | -567.53% | — |
| Operating Margin % | -8.13% | -8.09% | -9.45% | — |
| Gross Margin % | 70.76% | 70.8% | 69.09% | — |
| EBITDA Margin % | -22.84% | 5.82% | -555.65% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.